Video

Emerging therapies in AMD management

Author(s):

OT Staff Reports

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

See more AMD Awareness content here, here, and here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
NIH study identifies brain circuits critical to visual acuity beyond the retina
June 12th 2025

NIH study identifies brain circuits critical to visual acuity beyond the retina

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD
June 7th 2025

A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801
June 5th 2025

ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801

Ocugen signs term sheet for korean licensing of OCU400 gene therapy
June 5th 2025

Ocugen signs term sheet for korean licensing of OCU400 gene therapy

© 2025 MJH Life Sciences

All rights reserved.